Skip to main content
. 2018 Feb 6;8:2521. doi: 10.1038/s41598-018-20617-5

Figure 3.

Figure 3

Protection of human neutrophils by the anti-cancer drugs. S. aureus USA300 (106 CFU) and human neutrophils (105 cells) were mixed, and the test compounds were added to the concentration indicated for 4 h. The viability of human neutrophils was measured by CellTiter assay (Promega). In the graph, the OD490 in the absence of compound was set to 100%.